About the Company
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on BIO-TECHNE Corp
Here’s What Dragged Bio-Techne Corporation (TECH)?
Bio-Techne Corporation (NASDAQ:TECH), with a market capitalization of $11.338 billion, develops, manufactures, and sells life science reagents, instruments, and services for the research and ...
Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?
Bio-Techne Corporation TECH is set to release fourth-quarter fiscal 2025 results on Aug. 6, before the opening bell. The life science and diagnostic product maker posted adjusted earnings per share ...
Should You Hold Bio-Techne Corp. (TECH) For the Long Term?
Bio-Techne Corporation (NASDAQ:TECH), with a market capitalization of $7.846 billion, develops, manufactures, and sells life science reagents, instruments, and services for the research and ...
Bio-Techne Corporation: Long-Term Quality, But At A Price
The Bio-Techne Corporation share count rose to 161 million, but that is a technicality following the split of course, with the company now awarded a $13.2 billion valuation at $82 per share.
Bio-Techne Corporation (TECH) Declined on Weak Q4 Results
One-month return of Bio-Techne Corporation (NASDAQ:TECH) was 28.06%, and its shares gained 0.04% of their value over the last 52 weeks. Bio-Techne Corporation (NASDAQ:TECH) has a market ...
Bio-Techne Corp. stock outperforms competitors on strong trading day
Bio-Techne Corp. closed 34.74% below its 52-week high of $80.95, which the company achieved on September 19th.
Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Recommendation of ...
Bio-Techne had a return on equity of 13.17% and a net margin of 10.89%. The firm had revenue of $316.18 million for the quarter, compared to analyst estimates of $317.92 million.
Is Bio-Techne Corporation's (NASDAQ:TECH) Latest Stock Performance ...
Most readers would already know that Bio-Techne's (NASDAQ:TECH) stock increased by 4.7% over the past three months. Given its impressive performance, we decided to study the company's key ...
Bio-Techne Corporation (TECH) Slid on Rise in Investors’ Concerns
Bio-Techne Corporation (NASDAQ:TECH), with a market capitalization of $8.58 billion, develops, manufactures, and sells life science reagents, instruments, and services for the research and ...
Bio-Techne Corp. stock underperforms Thursday when compared to competitors
Shares of Bio-Techne Corp. TECH slipped 1.77% to $53.74 Thursday, on what proved to be an all-around mixed trading session ...
Bio-Techne Corp (TECH) CEO Charles Kummeth on Q3 2019 Results ...
Bio-Techne Corp (NASDAQ:TECH) Q3 2019 Earnings Conference Call April 30, 2019 9:00 AM ET Company Participants James Hippel - SVP, Finance & CFO Charles Kummeth - CEO, President & Director ...
Bio-Techne Corp. Q2 Adj. Profit Rises; Organic Revenue Up 6% - Quick ...
Bio-Techne Corp. announced that its Board has decided to pay a dividend of $0.32 per share for the quarter ended December 31, 2019.
Similar Companies
Loading the latest forecasts...